Search
Powered By HealthLine
Special Offers
Health Tools
 Chemotherapy: Eating Adivce
 Chemotherapy Myths
 Chemotherapy Guide
 Stages of Chemotherapy
 Post-Chemo Accessories
Featured Conditions
 Diet & Exercise
 Breast Cancer
 Skin Cancer
 Prostate
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Herb May Counter Liver Damage From Chemo

Milk thistle appears to reduce liver inflammation in cancer patients, researchers say

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Arteriohepatic Dysplasia
Basal Cell Carcinoma
Bladder Cancer
More...

Related Healthscout Videos
 border=
Growing Lungs in the Lab: Medicine's Next Big Thing?
From Belly to Breast: Rebuilding After Cancer
Shaving off Cancer
Fluorescent Medicine for Brain Tumors
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
Hepatitis
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Scientists Find Protein That May Help Control Prostate Cancer
Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment
FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
Lifestyle Key to Preventing Stroke, Guidelines Say
More...

MONDAY, Dec. 14 (HealthDay News) -- A medicinal herb, milk thistle, appears to reduce liver damage resulting from chemotherapy, a new study finds.

Chemo drugs often cause liver inflammation, making it necessary to lower the dose or suspend treatment until the inflammation subsides. These interruptions in therapy can make treatment less effective, the researchers said.

Text Continues Below



"We found that milk thistle, compared to placebo, was more effective in reducing inflammation," said lead researcher Dr. Kara Kelly, from New York-Presbyterian Hospital/Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center in New York City.

"If these results are confirmed, milk thistle may allow us to treat liver inflammation or prevent it from occurring, which will allow better delivery of chemotherapy drugs," she added.

The report is published in the Dec. 14 online edition of Cancer.

Milk thistle, a longtime folk remedy, is often recommended to treat liver damage and mushroom poisoning. No other treatment for liver toxicity exists, Kelly said.

For the study, Kelly's team randomly assigned 50 children undergoing chemotherapy for acute lymphoblastic leukemia to receive milk thistle or a placebo for 28 days. All the children had liver inflammation at the start of the study.

Twenty-eight days later, the children who had received milk thistle had improved liver enzymes, compared with the children who received a placebo, the researchers said.

The milk thistle group had significantly lower levels of one enzyme in particular, AST, and a trend towards lower levels of another enzyme called ALT, Kelly's group found.

In addition, milk thistle appeared to help patients tolerate higher doses of chemotherapy. Sixty-one percent of the children receiving milk thistle needed dose reductions, compared with 72 percent of the children receiving placebo, but this difference is not significant, the researchers noted.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 12/14/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Kara Kelly, M.D., New York-Presbyterian Hospital/Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York City; Julio C. Barredo, M.D., director, pediatric hematology-oncology, University of Miami Miller School of Medicine; Dec. 14, 2009, Cancer, online


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire